VAERS reports by lot

Moderna COVID-19 lot AS7166B: VAERS reports

127 VAERS reports list lot AS7166B as a Moderna COVID-19 vaccine, received between 2022-09-29 and 2024-02-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
127
Reports
5%
Marked serious
1
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8727%
Neurological4715%
Cardiac / Cardiovascular4614%
Respiratory3511%
Gastrointestinal3511%
Injection-site / Local reaction258%
Musculoskeletal144%
Dermatological (non-injection-site)134%
Allergic / Anaphylactic72%
Autoimmune / Immune-mediated52%
Psychiatric / Neuropsychiatric41%
Thrombotic / Hematological21%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Minnesota14
Pennsylvania9
Florida9
Kansas9
Michigan8
Texas7
New Jersey6
California6
Ohio5
Oregon4
Colorado4
Arizona4

Reports by month received

2022-093
2022-1014
2022-1111
2022-1260
2023-0115
2023-022
2023-038
2023-048
2023-052
2023-071
2023-112
2024-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.